 |
 |
|
|
|
|
|
|
|
| | | |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1
.
SEC LITIGATION RELEASE
|
EXTRACTED KEY WORDS
EXCHANGE PERIODIC REPORTS SECURITIES COMPLAINT FILING EXCHANGE ACT INAMED CORPORATION DISTRICT COMPLAINT ALLEGES WASHINGTON LITIGATION INAMED CORPORATION CIVIL UNITED STATES DISTRICT STATES DISTRICT COURT COLUMBIA MEDICAL PRODUCTS COMPANY PINK SHEETS ACCURATE INFORMATION FINANCIAL CONDITION ANNUAL REPORT NOTIFICATION DELINQUENT PERIODIC REPORTS VIOLATIONS THEREUNDER ENTRY JUDGMENT GRANTING RELIEF |
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
Litigation Release No. 15647 / February 19, 1998
Securities and Exchange Commission v. Inamed Corporation
Civil No. 98-CV-00431 (D.D.C.) (filed February 18, 1998)
On February 18, 1998, the Commission filed a complaint in
the United States District Court for the District of
Columbia against Inamed Corporation ("Inamed"). The
complaint alleges that Inamed, a medical products company
whose securities are quoted in the pink sheets, failed to
make available to the investing public current and accurate
information about its financial condition and results of
operation through the filing of periodic reports with the
Commission as required by the Securities Exchange Act of
1934 ("Exchange Act"). Specifically, the complaint alleges
that Inamed has not filed its Annual Report on Form 10-K for
the fiscal year ended December 31, 1996 and a Notification
of Late Filing with respect to that report. The Commission
seeks to compel Inamed to file its delinquent periodic
reports and enjoin Inamed from further violations of Section
13(a) of the Exchange Act of 1934 and Rules 12b-25 and 13a-1
thereunder. Simultaneously with the filing of the
Commission's complaint, Inamed consented to the entry of a
Final Judgment granting the relief sought by the Commission
and admitted that it had not filed the periodic reports as
described above.
SNIPPETS:
|
|
|
| | | |
|
|
